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PENGENALPASTIAN PROTEIN PERUMAH BERIMUNOGENIK DI 
DALAM SERA PESAKIT SEL KARSINOMA SKUAMA ORAL (OSCC) 
 
ABSTRAK 
 
Kanser mulut adalah kanser ke-enam paling lazim di dunia dan sel karsinoma 
skuama oral (OSCC) yang berasal dari mukosa mulut membentuk lebih daripada 
90% kemalignan dan menjana hampir 300,000 kes baru setiap tahun. Cabaran utama 
untuk meningkatkan kadar kemandirian pesakit OSCC adalah disebabkan kanser 
mulut sering tidak dikesan sehingga peringkat lewat dan hanya separuh daripada 
mereka yang disahkan menghidap penyakit tersebut masih hidup selepas lima tahun 
manakala pesakit peringkat awal mempunyai kadar kemandirian 5 tahun yang sangat 
baik iaitu lebih daripada 80%. Oleh itu, pembangunan penanda biologi untuk OSCC 
yang sesuai dan tepat amat diperlukan untuk membantu dalam pengesanan awal 
sekaligus boleh mengurangkan kematian berkaitan dengan kanser mulut. Dalam 
kajian ini, elektroforesis dua dimensi (2-DE) dan teknik pemedapan-immuno telah 
digunakan untuk mengenal pasti penanda-edaran dalam sera pesakit OSCC. Profil 
protein yang diperolehi, dibanding dan dianalisa menggunakan perisian PDQuest dan 
seterusnya dikenal pasti dengan teknik pemedapan Barat menggunakan serum 
terkumpul (antibodi primer) dan monoklonal anti-manusia IgM-HRP (antibodi 
sekunder). Protein yang dikehendaki untuk dikaji kemudiannya dikenal pasti dan 
dicirikan dengan menggunakan spektrometri jisim MALDI-TOF/TOF diikuti oleh 
maskot protein carian pangkalan data. Perbezaan dalam pengekspresan protein α1-B-
Glikoprotein (ABG), haptoglobin (HAP), klusterin (CLU), leusin yang kaya dengan 
α2-Glikoprotein (LRG), retinol mengikat protein 4 prekursor (RBP4), PRO2044, dan 
xii 
 
proapolipoprotein (Proapo-AI) diperhatikan dalam serum pesakit OSCC apabila 
dibandingkan dengan serum individu yang sihat. Daripada protein-protein tersebut, 
hanya empat protein perumah iaitu CLU, HAP, Proapo-AI dan RBP4 mempamerkan 
keimunogenikkan dalam pemedapan Barat manakala lima protein bukan perumah 
yang dihipotesiskan sebagai protein Acinetobacter lwoffii, Burkholderia multivorans, 
Myxococcus xanthus, Laribacter hongkongensis dan hemolysin A Streptococcus 
salivarius turut diperhatikan. Kajian ini boleh dianggap sebagai batu loncatan dalam 
pembangunan penanda protein yang berpotensi untuk memudahkan pengenalan 
OSCC di peringkat awal. Tambahan pula, pendekatan menganalisa hubungan OSCC 
dengan bakteria telah menunjukkan beberapa hasil yang menjanjikan dan 
bermaklumat. 
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DETECTION OF HOST-SPECIFIC IMMUNOGENIC PROTEINS IN THE 
SERA OF ORAL SQUAMOUS CELL CARCINOMA (OSCC) PATIENTS 
 
ABSTRACT 
 
Oral cancer is the sixth most prevalent cancer in the world and the predominant type, 
oral squamous cell carcinomas (OSCCs) deriving from the oral mucosa constitute 
more than 90% of malignancies and generating nearly 300,000 new cases annually. 
The main challenge of improving the survival rate of OSCC patients is that oral 
cancer is often not detected until the later stages resulting in only half of those 
diagnosed with the disease surviving more than five years. The early-stage patients 
have an excellent 5-year survival rate of more than 80% unlike the late stages 
patients Therefore, the development of suitable and reliable biomarkers of OSCC is 
greatly needed to assist in early detection which may reduce the mortality associated 
with oral cancer. In this study, two dimensional gel electrophoresis (2-DE) and 
immunoblotting techniques were employed to identify novel circulating markers in 
sera from OSCC patients. The protein profiles obtained were compared and analyzed 
using PDQuest software and were further identified with immunoblotting using 
pooled sera (primary antibody) and monoclonal anti-human IgM-HRP (secondary 
antibody). The spots of interest were identified using MALDI-TOF/TOF mass 
spectrometry followed by MASCOT protein database search. Differences in the 
expressions of alpha-1-B-glycoprotein (ABG), haptoglobin (HAP), clusterin (CLU), 
leucine-rich α2-glycoprotein (LRG), retinol binding protein 4 precursors (RBP4), 
PRO2044, and proapolipoprotein (Proapo-AI) were observed in OSCC patients’ sera 
when compared with normal controls. Of those proteins, only four host specific 
xiv 
 
proteins namely CLU, HAP, Proapo-AI and RBP4 exhibited immunogenicity in 
Western blots whilst five non-host hypothetical proteins of Acinetobacter lwoffii, 
Burkholderia multivorans, Myxococcus xanthus, Laribacter hongkongensis and 
hemolysin A of Streptococcus salivarius were also observed. This study can be 
perceived as a stepping stone in the development of potential protein markers that 
facilitate the identification of OSCC at an early stage. In addition, the approach of 
analyzing the relationship of OSCC with bacteria has shown some very promising 
result which is significantly informative. 
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CHAPTER ONE 
 
INTRODUCTION 
 
1.1. Oral Cancer 
Oral cancer can be subdivided into three categories namely carcinoma of the oral 
cavity proper, carcinomas of the lip vermilion and carcinomas arising in the 
oropharynx (Neville and Day, 2002; Llewellyn et al., 2001). Malignancies arising in 
the lip, teeth, gum, tongue, floor of the mouth, gingivae, palate, buccal mucosa and 
salivary glands are categorized as cancers of the oral cavity (Silverman, 2001). 
Although there are several types of malignant oral cancers, more than 90% of these 
malignant neoplasms are squamous cell carcinomas (SCCs) developing in the 
mucous membranes of the mouth and oropharynx (Chen and Myers, 2001). Oral 
cancer is an epithelial neoplasia and it is believed that OSCC follows a comparable 
pattern in its development. Epithelial neoplasia generally begins as a focal clonal 
overgrowth of altered stem cells near the basement membrane, expanding laterally 
and upward, replacing the normal epithelium and progressing through hyperplasia to 
dysplasia to carcinoma in situ and invasive carcinoma (Turhani et al., 2006). Oral 
cancer is atypical in that it carries a high risk of second primary tumors. Survivors of 
the first oral cancer have up to 20-fold increased risk of developing a second primary 
oral cancer. That risk lasts for five to ten years and sometimes longer (Mager et al., 
2005). 
 
A fundamental barrier to improving the survival rate in OSCC relates to the fact that 
it often remains undetected until later stages despite the accessibility of oral cavity to 
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direct examination. Oral cancer has been reported as having one of the highest 
mortality ratios amongst all malignancies by World Health Organization (Parkin et 
al., 2001). As a matter of fact, oral cancer has not seen a drop in its 50% mortality 
rate over the past 30 years (Kujan et al., 2005), and as a result only half of those 
diagnosed with the disease survive more than five years. In fact, it was reported that 
a few months delay in diagnosis can reduce a patient’s chance of survival from 80% 
to 40% (Lin et al., 2006). High rates of second oral malignancies were also related to 
oral cancer in which up to 30% of patients suffered a recurrence of the tumor or 
development of a second primary tumor even with intensive follow-up (Dhooge et 
al., 1998; Poh et al., 2011). 
 
1.2. Epidemiology  
Albeit oral cancer being the eighth most common cause of cancer-related deaths 
globally, large numbers of people are still unaware of its existence (Parkin et al., 
2005). In developing countries, mouth and pharynx is the sixth and eighth most 
common sites for malignant disease among men and women respectively (Johnson et 
al., 2011). High incidence rate of oral cancer as reported in South and South East 
Asia which accounts for more than 180,000 cases annually (Bofetta and Parkin, 
1994). In Malaysia particularly, the prevalence of oral cancer was 0.04% as reported 
by Zain et al. (1997)  
 
Predominantly, oral cancer occurs in males after the fifth decade of life. In Asian 
populations, the mean age of oral cancer patients is in the fifties and early sixties 
(Johnson et al., 2011). In recent years, incidence of oral cancers among younger 
people is on the rise. Oral cancers were increasingly reported to occur at ages 
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younger than forty five years especially in the high prevalence areas of the world 
where heavy uses of tobacco were reported (Llewellyn et al., 2004; Elango et al., 
2006). Males had a higher mean global age-specific incidence of mouth and 
pharyngeal cancer when compared to females. However, the disparity of oral 
malignancies between males and females has become less prominent over the past 
fifty years (Neville and Day, 2002; Hooper et al., 2009). 
 
Variations by ethnicity were illustrated globally. Asians are most likely to develop 
malignancies in the buccal mucosa, African Americans males in the USA have a 
high incidence of oral and pharyngeal cancer while lip cancer is increasing in 
Australia (Johnson et al., 2011). In Malaysia, Zain et al. reported in 1997 that other 
Bumiputera (indigenous people of Sabah and Sarawak) exhibited the highest 
percentage of subjects with oral mucosal lesions with 17.97%, followed by Indians, 
14.81%, Chinese, 9.53% and Malays, 7.49%. Other Bumiputera (as mentioned 
above) also have the highest prevalence of oral carcinoma with 1.9/1000 population. 
In 2007, National Cancer Registry (NCR) stated that among 353 cases of oral cancer 
reported in Malaysia, 182 were females. Incidence of oral cancer was also reported 
as highest in Indian females where the ASR was 10.2/100000 female populations. Of 
those oral malignancies cases reported with staging, only 35% were diagnosed at 
stage I and II (NCR, 2007). Early diagnosis is imperative. 
 
1.3. Etiology 
Oral squamous cell carcinoma is commonly associated with tobacco in various 
forms, areca nut or betel quid chewing, heavy alcohol consumption and also 
microbial factors. The usage of tobacco and areca nut, either simultaneously or alone, 
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accounts for the majority of oral cancers and oral potentially malignant disorders 
(Amarasinghe et al., 2010). Areca nut which is an independent risk factor for oral 
cancer is a common component of different chewing habits and classified as 
carcinogenic to humans by the WHO (Warnakulasuriya et al., 2002). Poor oral 
hygiene due to increment of microbial load and chronic trauma from ill-fitting 
dentures or sharp restorations may also contribute as risk factors for oral cancer. 
 
1.3.1. Betel Quid 
Betel quid chewing habit has been mentioned as early as 600 A.D. in the Sanskrit 
and can be traced back locally in 1664, in which an impost duty on betel leaf 
imported from India into Malacca was mentioned in the Dutch archives (Muir and 
Kirk, 1960). In general, a betel quid consists of betel leaf, areca nut, slaked lime and 
also tobacco. Based on local preference, other substances such as cardamom, saffron, 
cloves, aniseed, turmeric, mustard or sweeteners were also included (Norton, 1998; 
Neville and Day, 2002). Betel quid with or without the addition of tobacco is 
considered as carcinogenic to humans hence provide a risk of oral cancer and 
potentially malignant disorders development (Warnakulasuriya et al., 2002; Bagan 
and Scully, 2008). 
 
1.3.2. Areca Nut 
The seed of the oriental palm Areca catechu is termed as areca nut. According to 
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 85; 
areca nut consumption is common in India, Sri Lanka, Bangladesh, Taiwan and 
Melanesia. It is also popular in parts of South-East Asian countries such as Thailand, 
Indonesia, Cambodia, including Malaysia and in emigrant communities from these 
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countries. It is estimated about 20% of the world’s population, approximately 600 
million people worldwide used areca nut as a masticatory substance (Johnson et al., 
2011). 
 
Areca nut constitutes mainly of carbohydrates, fat, proteins, fiber, polyphenols 
(flavanols and tannins), alkaloids and minerals. In the mouth, nitrosation of the 
alkaloids in dried stored nuts produced nitrosamines and especially in the acid 
conditions of the stomach with the presence of nitric oxide generated by bacteria as 
reported in IARC Monographs (Volume 85). Subjects with poor oral hygiene 
significantly have higher endogenous nitrosation and more extensive nitrosamine 
formation take place if they also chew tobacco. According to IARC Monographs 
(Volume 82), fungi such as Aspergillus flavus, Aspergillus niger and Rhizopus spp. 
may contaminate the areca nut. Aflatoxins produced by the contaminants, which are 
established carcinogens were found in almost 40% of areca nut samples analyzed 
using thin-layer chromatography.  
 
1.3.3. Slaked Lime 
Slaked lime (calcium hydroxide) is commonly obtained by heating sea shells or 
harvested from corals in coastal areas of Sri Lanka and islands of the pacific whereas 
in inland areas, it is quarried from limestone. Erosion of the oral mucous membranes 
can developed when slaked lime is added into betel quids hence facilitate penetration 
of betel quid carcinogens through the mucosa (Johnson et al., 2011). 
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1.3.4. Smokeless or Chewing Tobacco  
Tobacco, originated from cut leaves of Nicotiana tabacum and Nicotiana rustica are 
frequently added to the betel quid. Not less than sixteen carcinogens including 
tobacco-specific nitrosamines and polycyclic aromatic hydrocarbons are exposed to 
the oral mucosa when chewing tobacco takes place (Petti, 2009). Carcinogenic 
tobacco-specific nitrosamines; N-nitrosonornicotine (NNN) and 4-
(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were highly expressed in 
saliva of tobacco chewers and oral snuff users (Idris et al., 1992; Nilsson, 2011). 
Abundance of reactive oxygen species are released when chewing betel quid and 
especially whilst the quid is still present. As major genotoxic agents, both tobacco-
specific nitrosamines and reactive oxygen species involved in oral cancer are 
associated with the use of chewing tobacco as reported by IARC Monographs 
(Volume 85). Smokeless tobaccos mostly have high levels of nicotine, addictive and 
can also be initiators of smoking (Haddock et al., 2001). In addition, they have 
significant cardiovascular effects and produce oral mucosal lesions as well as local 
damage to the periodontium (Critchley and Unal, 2003). 
 
1.3.5. Tobacco Smoking 
As the foremost preventable cause of premature death worldwide, tobacco is a major 
etiological risk factor for the development of oral and pharyngeal cancer and other 
malignancies of upper aero-digestive tract (Johnson et al., 2011). It is estimated that 
10 million deaths per year will occur by 2020, of which 70% will be in developing 
countries due to tobacco-related illness (Warnakulasuriya et al., 2005). Risk of 
developing oral cancer is five to nine times greater for smokers compared to non-
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smokers. Approximately 80% of oral cancer patients smoked, that is two to three 
times greater compared to the general population (Neville and Day, 2002). 
 
Tobacco contains as much as 6000 different compounds in the particulate and vapour 
phases. In addition to nicotine, these compounds comprise polycyclic aromatic 
hydrocarbons, tobacco glycoprotein and some metals; many of which are known to 
be antigenic, cytotoxic, mutagenic or carcinogenic (Arnson et al., 2010). 
Carcinogenic NNK, NNN and polycyclic aromatic hydrocarbons particularly have 
been linked to upper aero-digestive tract cancer. Smoking and exposure to nicotine 
influences the immune system in many ways.  Immunosuppression effects involving 
reductions of antigen presenting activity, circulating immunoglobulins, T-cell 
activity and neutrophil activity were observed in smokers. Pro-inflammatory effects 
were also demonstrated whereby augmentation of acute phase and pro-inflammatory 
reactants, neutrophil count, circulatory T-cells and free radical burden take place 
(Arnson et al., 2010). 
 
1.3.6. Alcohol  
Alcohol consumption has been identified as a major public health problem 
worldwide as well as major risk factor for cancers of the upper aerodigestive tract. 
Carcinogenic effect of alcohol was first reported in 1960’s and has been replicated 
since (Ketcham et al., 1963; Bofetta and Hashibe, 2006).Cook reported in 1998 that 
immune surveillance can be reduced with alcohol drinking thus favouring cancer 
development and metastatic potential (Cook, 1998). Pure ethanol does not show 
carcinogenicity in animal studies (Boyle et al., 2003), but other components of 
alcoholic drinks including impurities and contaminants might increase cancer risk. N-
 8 
 
nitrosodiethylamine found present in some beer and whisky is associated with an 
increased risk of oral cancer as well as polycyclic aromatic hydrocarbons which 
some are considered to be carcinogenic (Ogden and Wight, 1998). 
 
Alcohol dehydrogenase and aldehyde dehydrogenase are the major alcohol-
metabolizing enzymes where they oxidize ethanol to acetaldehyde and detoxify 
acetaldehyde to acetate respectively. Due to its multiple mutagenic effects on DNA, 
acetaldehyde is responsible for the oral carcinogenic effect of ethanol (Johnson et al., 
2011). Alcohol can promote oncogenesis through impairment of phospholipids of 
cell membranes by ethanol therefore increases permeability and enhancing the 
penetration of carcinogens across the oral mucosa (Howie et al., 2001). Ethanol also 
acts as a solvent and impairs DNA repair mechanisms thus allowing penetration of 
carcinogens through the mucosa, possibly catalyzing the activation of carcinogenesis 
(Bofetta and Hashibe, 2006). Ethanol is also hepatotoxic and caused the effectiveness 
of enzyme systems central to the detoxification of carcinogens such as glutathione-S-
transferases to reduce. Super-multiplicative synergistic effects of alcohol and 
smoking were extensively reported since 1970’s wherein some subsets of patients 
who are extremely heavy smokers and heavy drinkers can have 100 times greater risk 
for developing a malignancy (Rothman and Keller, 1972; Zeka et al., 2003; 
Salaspuro and Salaspuro, 2004; Bofetta and Hashibe, 2006).  
 
 
 
 
 
 9 
 
1.3.7. Diet and Nutrition 
Dietary factors are estimated to account for approximately 20% of all cancers in the 
developing countries (Cancer: Diet and Physical Activity’s Impact, WHO). There 
have been extensive studies in associations with diets and oral cancer and precancer 
in the last three decade. Insufficient intake of fresh fruits and vegetables has been 
consistently linked with an increase in cancer prevalence or incidence (Levi et al., 
1998; Lucenteforte et al., 2009). Through a meta-analysis of existing epidemiologic 
studies, Pavia et al. (2006) observed an overall 49% and 50% reduction on oral 
cancer risk for each portion of fruit and vegetables consumed per day respectively 
(Pavia et al., 2006). 
 
Vitamin A, C and E and related carotenoids (in particular beta-carotene) and 
selenium appear to decrease incidence of epithelial cancer. The concentrations of 
these nutrients are found to be relatively high in the serum although the adrenal and 
pituitary glands, the brain, white blood cells and platelets showed higher 
concentrations compared to serum (Machlin and Bendich, 1987). The protective 
effect of these micronutrients attributed to their antioxidant activities that act by 
reducing free radical reactions that can cause DNA mutations and changes in lipid 
peroxidation of cellular membranes and changes in enzymic activities (Machlin and 
Bendich, 1987; Schwartz and Shklar, 1988; Du et al., 2002). Micronutrients are also 
responsible in modulation of carcinogen metabolism, maintenance of immune 
function, inhibition of endogenous carcinogens formation and influence cell 
transformation and differentiation (Zain, 2001). Serum vitamins A, B12, C, E, beta-
carotene and foliate were shown by Ramaswamy and his colleagues, to be decreased 
in leukoplakia patients compared to controls (Ramaswamy et al., 1996). In Japan, 
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another study also reported a significant difference in serum levels of lycopene and 
beta-carotene in those with leukoplakia compared to control (Nagao et al., 2000). 
 
1.4. Microorganisms and Cancer 
Oral cancer is considered to be a multi-factorial disease, as it can stem from exposure 
to several types of carcinogens, including microbial factors (Kalu U. E. Ogbureke, 
2012). The existence of relationships among certain bacteria and cancers continue to 
be promulgated albeit bacterial mechanisms involved are at present unclear (Mager, 
2006). It is estimated around 15% of malignancies (about 1.5 million cases) 
worldwide can be attributed to viral, bacterial and other pathogens annually 
(Srivastava et al., 2005). For most associations between infection and malignancies, 
it is still unknown whether the bacterial infection is a marker of disease or is causally 
related to tumour formation except for Bartonella (Dehio, 2005) and Helicobacter 
pylori (Rogers et al., 2005) infections which have been shown to induce tumour 
formation.  
 
Several pieces of evidence have supported the association of microbial infection with 
oncogenesis. For instance, association of H. pylori with two different forms of gastric 
cancer; mucosa associated lymphoid tissue (MALT) lymphoma and adenocarcinoma 
is the utmost-studied relationship between a bacterial infection and cancer to date 
and are also categorized by the IARC (WHO) as a carcinogenic factor in humans 
(Peek and Blaser, 2002; Björkholm et al., 2003; Marshall and Windsor, 2005; Correa 
and Houghton, 2007). Similarly, Chlamydophila pneumonia has been associated with 
malignant lymphoma and lung cancer in males (Anttila et al., 1998; Kocazeybek, 
2003), whereas Candida albicans and Streptococcus anginosus were linked to oral 
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carcinomas (Sasaki et al., 2005; Hooper et al., 2009). It is also known that OSCC 
patients tend to possess significantly elevated concentrations of certain bacteria in 
their saliva. Thus, changes in salivary microflora may represent a non-invasive 
diagnostic tool for predicting oral cancer (Hooper et al., 2009). 
 
Hence, to understand the pathogenesis and prevention of certain cancers, it may 
perhaps be achieved by studying the bacterial infections associations and their effects 
on the host (Vogelmann and Amieva, 2007). Nevertheless, the mechanisms by which 
cancer formation attributed by bacteria are complex and recent investigations showed 
involvements of deleterious alterations in physiological host processes such as 
inflammation, antigen-driven lymphoproliferation and induction of hormones that 
increases epithelial cell proliferation. Bacteria may also directly affect oncogenesis 
through production of toxic and carcinogenic metabolites (Chang and Parsonnet, 
2010). Bacteria, on their own are often insufficient to induce cancer but accompanied 
by chronic inflammation and independent mutations in oncogenic signaling 
pathways, the tumour formation process might occur (Vogelmann and Amieva, 
2007). There is evidence that epidemiological and etiological links between 
microbial infection and oral cancer could exist. The activation of pro-carcinogenic 
substances by the oral microflora, specifically the conversion of ethanol to 
acetaldehyde, may be an important etiological factor (Hooper et al., 2009). 
 
The oral cavity is home to a diverse microflora comprising many microbial species, 
each present in varying amounts. The composition and quantity of this microflora 
differ from each individual and can change throughout the lifetime in response to a 
variety of factors (Marsh and Percival, 2006). There have been only a few 
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investigations into the possible associations between bacterial species and oral 
carcinoma thus far. The presence of Candida albicans, a common oral commensal, 
has long been recognized as an independent risk factor for malignant transformation 
(Cawson, 1969). An intraoral carcinomas study done by Nagy et al., (1998) 
demonstrated an increased numbers of certain members of oral bacteria on the 
surface of tumours in comparison with control sites. Other studies have also 
demonstrated elevation of some common microflora on or in the lesions and their 
associated lymph nodes (Mager et al., 2005; Hooper et al., 2007; Westphal et al., 
2008) It was presumed that such selectivity occurred because the bacteria were 
effectively shielded from the host immune system while being within the solid 
tumour (Yong et al., 2004). Previous research as well has shown that oral bacteria 
exhibit specific tropisms toward different biological surfaces such as the teeth and 
mucosa (Gibbons, 1996). This pattern of specificity suggests that different intra-oral 
surfaces and bacterial species have different receptors and adhesion molecules that 
influence the colonization of different oral surfaces (Mager et al., 2005). 
 
1.5. Proteomics 
As the final products manufactured in living cells, protein is important in the 
annotation of the genome. The word ‘proteome’ was first describes as a set of all 
proteins expressed by a given genome in which complementary to studies at the 
transcript level (Wasinger et al., 1995). In emphasizing its dynamic nature, a more 
specific definition of proteome was describes as a set of proteins that provides 
information on proteins that are expressed in a biological compartment at a particular 
time, under a particular set of conditions, as its composition may vary from tissue to 
tissue or even from cell to cell (Beranova-Giorgianni, 2003). In principal, proteome 
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offers richer source for the functional description of diseases. Specific properties of 
proteins such as post-translational modifications, various conformation states and 
alternative splicing illustrate the multidimensionality, high variability and dynamic 
nature of the proteomic information (Tambor et al., 2010). This may be of particular 
importance for diseases such as cancer, which evolve dynamically and affect many 
heterogeneous cell populations either as part of the cancer or as part of the host’s 
reaction to the tumour (Kolch et al., 2005). Since the molecular pathways in normal 
and transformed cells were influenced by protein molecules, proteomic markers are 
more relevant to the disease state initiation and progression (Mishra and Verma, 
2010). Proteomics cover of a broad scope whereby it encompasses identification and 
quantification of proteins in cells, tissues and biological fluids; analysis of changes in 
protein expression in normal versus diseases cells; characterization of post-
transcriptional modifications; studies of protein-protein interactions and other 
applications. 
 
Two dimensional gel electrophoresis (2-DE), mass spectrometry (MS) and 
bioinformatics tools are the key components of an approach that has been termed ‘the 
classical proteomics methodology’. 2-DE was first introduced in the early 1970s by 
O’Farrell (1975). In 2001, serological proteome analysis (SERPA) has been 
proposed for a top-down approach usable for discovery-driven immunomics by 
Klade and his colleagues (Klade et al., 2001). SERPA or also termed as 
PROTEOMEX by Seliger and Kellner, (2002) is based on a classical proteomics 
workflow associating an effective separation on 2-DE gels and an identification by 
MS. SERPA allows the transfer and immobilization of proteins from tumour tissue or 
tumour cell lines to a semirigid support with the combination of Western blotting and 
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2-DE gels. Sera from cancer patients or healthy subjects were screened; allowing 
immunodetection of relevant antigens among the several thousand individual 
proteins separated using 2-DE. Comparative probing of blots with sera from patients 
and healthy subjects may allow the identification of associated antigens that elicit a 
humoral immune response with the sera from cancer patients specifically (Caron et 
al., 2007). 
 
1.6. Cancer Serology Using Proteomics Approach 
Cancer may be accompanied by the production and release of a substantial number of 
proteins or hormones into the blood that could serve as useful markers for assessing 
prognosis, monitoring treatment and detecting malignant disease at an early stage. 
Therefore, utilizing serum profiling in diagnosing cancer is certainly an appealing 
concept. In addition to protecting us against pathogens, the immune system is also on 
guard against other threats, including tumours (Tan, 2001). Generation of circulating 
antibodies that bind to self-protein can be deemed as the systemic amplification by 
the immune system of a signal that indicates presence of the tumor (Purcell and 
Gorman, 2004). 
 
Serum is a commonly used matrix to screen for biological markers, which 
subsequently has been proven to be very useful in the diagnosis, prognosis, treatment 
and/or early detection of disease. Serum is derived from coagulated blood in which 
fibrin clots formed, blood cells and related coagulation factors are separated from 
serum by applying centrifugal force. During this process, proteins are released by 
platelets into the serum. When average metabolite concentrations were compared 
between subjects with different phenotypes, serum demonstrated higher sensitivity 
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compared to plasma thus revealed more potential in biomarkers detection (Yu et al., 
2011).  
 
Differences in the expression of some serum proteins may be an early sign of an 
altered physiology that may be indicative of disease (Poon and Johnson, 2001).The 
study of proteomics had contributed to significant advances in understanding cancer. 
Numerous studies on protein expression in different types of cancers had been done 
and published. These findings have provided important information on functional 
cellular processes. A list of cancer biomarker studies using proteomics approach is 
tabulated in Table 1.1. 
 
Table 1.1: Cancer serology studies using proteomics analysis approach. 
Cancer type References 
Breast cancer Doustjalali et al., 2004; Kyselova et al., 2008; 
Gromov et al., 2010 
Colorectal cancer Kim et al., 2009 
Nasopharyngeal cancer Doustjalali et al., 2006 
Prostate Li et al., 2004; Han et al., 2012 
Lung cancer Yang et al., 2007; Hongsachart et al., 2009 
Liver cancer Looi et al., 2008; Zinkin et al., 2008; Liu et 
al., 2011 
Pancreatic cancer Fiedler et al., 2009; Wingren et al., 2012 
Head and neck cancer Ralhan et al., 2011 
Gastric cancer Liu et al., 2012 
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1.7. IgM Antibody 
The term antibodies were first used by Karl Landsteiner in 1900 which is a 
translation from a German word “Antikörper” (Vollmers and Brändlein, 2005). 
Immunoglobulin M (IgM) antibodies are present in the circulation of normal humans 
and other mammalian species as part of the innate immunity and were conserved in 
all animals (Parkin and Cohen, 2001; Marchalonis et al., 2002). Pentameric IgM 
molecules made about 30% of the blood-circulating immunoglobulins in human. IgM 
is initially secreted by B cells upon primary stimulation with antigen (Zouali, 2001; 
Tchoudakova et al., 2009) and participates in natural defenses against foreign 
pathogens as well as neoplastic cells and tumors (Brändlein et al., 2003).  
 
In fact, autoantibodies against specific cancer antigens have been identified for 
several types of tumors, including colon, breast, lung, ovary, prostate, and head and 
neck. These antibodies have been found to recognize over expressed (e.g., Her2), 
mutated (e.g., p53), or tissue-restricted (e.g., cancer-testis antigens) proteins, which 
are produced by cancer cells and elicit immune responses (Lin et al., 2007). 
Therefore, detection of such antibodies in patient sera can be exploited as a means of 
cancer diagnosis. Indeed, the specificity and sensitivity of the antibody response to 
low antigen levels make it an ideal screening or diagnostic tool for early 
identification of cancer biomarkers in serum-based assays. 
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Figure 1.1: Schematic depiction of IgM pentavalent structure. The joining (J) chain 
promotes formation of the IgM pentamer. The central protruding region 
increase interactions with key ligands (Ehrenstein and Notley, 2010) 
(http://www.nature.com/nri/journal/v10/n11/abs/nri2849.html) 
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1.8. Functional Annotation and Protein Interaction Analyses 
DAVID (Database for Annotation, Visualization and Integrated Discovery) 
bioinformatics resources are a high-throughput and integrated data-mining 
environment which able to systematically extracting biological features or meaning 
from large gene or protein lists (Huang et al., 2009). DAVID is uniquely 
characterized with integrated and expanded back-end annotation database, advanced 
modular enrichment algorithms and powerful exploratory ability (Sherman et al., 
2007; Alvord et al., 2007) 
 
Without ever making direct contact, proteins can catalyze subsequent reactions in a 
metabolic pathway, regulate each other transcriptionally or post-transcriptionally or 
jointly contribute to larger, structural assemblies. Furthermore, together with direct 
physical interactions, such indirect interactions constitute the larger superset of 
‘functional protein-protein associations’ or ‘functional protein linkages’ (Eisenberg 
et al., 2000). Protein-protein associations have proven to be a useful concept by 
which to group and organize all protein-coding genes in a genome. The complete set 
of associations can be assembled into a large network, which captures the current 
knowledge on the functional modularity and interconnectivity in the cell. Protein 
network information can aid in the interpretation of functional genomics data.  
 
The STRING (Search Tool for the Retrieval of Interacting Genes) database has been 
designed with the goal to assemble, evaluate and disseminate protein-protein 
association information comprehensively. The STRING v9.1 in particular, 
specializes in three ways. Firstly, it provides uniquely comprehensive coverage, with 
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more than one thousand organisms, five millions proteins and more than two hundred 
millions interactions stored. It is also one of very few sites to hold experimental, 
predicted and transferred interactions, together with interactions obtained through 
text mining. It also includes a vast of accessory information, such as protein domains 
and protein structures improving its day-to-day value for users. 
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1.9. Statement of the problem and rationale of the study 
The advent of proteomic technologies have allowed the extensive fractionation of 
proteins in biological specimens, analysis of peptides by MS and matching of mass 
spectra to peptide sequences in human genome and protein databases (Omenn et al., 
2006). The dynamic nature of the circulatory system and its constituents reflects 
diverse physiological or pathological states, and the serum-based biomarkers provide 
noninvasive tests for screening as well as disease classification and monitoring for 
cancer progression and regression (Hanash et al., 2008). Theoretically, each disease 
may be uncovered and characterized by its unique biomarker. However, rather than 
to see this biomarker as a single molecule, a biomarker should be regarded as a panel 
of up- and down-regulated proteins or proteins with altered posttranslational 
modifications, which differ in disease and normal state (Etzioni et al., 2003; Rifai et 
al., 2006). 
 
Even with advances in surgery, radiation and chemotherapy, oral cancer is one of the 
lowest five-year survival rate among major cancer sites and this rate has not 
significantly improved (Jou et al., 2010). In this present investigation, identification 
of novel OSCC biomarkers in order to promote the development of specific 
diagnostic tests for the early detection of oral cancer was aimed. The 
immunoproteomic approach employed in this study allowed the detection of 
immunogenic host-specific proteins in patient samples using pooled human 
antibodies. Thus, host- or tumor-specific proteins represented markers for the 
‘selected’ antibody. Proteomic analysis allows the characterization and quantification 
of proteins and peptides in biological samples (Arnott and Emmert-Buck, 2010). 
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Therefore, a combined analytical platform involving two-dimensional gel 
electrophoresis (2-DE) and mass spectrometry (MS) has been widely used for 
biomarker identification (Srinivas et al., 2001; Kolch et al., 2005; Karpova et al., 
2010). 
 
In the present study, unfractionated sera from OSCC patients and normal controls 
were subjected to 2-DE and immunoblot for protein profiling, followed by 
characterization of potential markers using MS. Notably, since the approach used 
involved patient serum, which is complex and consists of various proteins, it can 
potentially reflect numerous events occurring in vivo simultaneously (Yeng et al., 
2010). In addition to providing potential biomarkers for the early detection of oral 
cancers, this study contributes to the understanding of naturally occurring antibodies 
in cancer. 
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2.0. Objectives of the study 
 
The aims of this study were as follows: 
1) To develop the 2-DE serum protein profiles of patients with OSCC as well 
as that from normal individuals 
 
2) To identify serum proteins that are differentially expressed in the serum of 
OSCC patients 
 
3) To identify circulating immunogenic proteins and host specific proteins 
eliciting humoral responses in OSCC patients using immunoproteomics 
approach. 
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Figure 1.2: Summary on the whole of methodology performed in this study. 
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CHAPTER TWO 
 
MATERIALS AND METHODOLOGY 
 
2.1. Collection of Serum Samples 
Based on clinical information and laboratory diagnosis for carcinogenesis, a total 
of 25 serum samples of oral squamous cell carcinoma (OSCC) patients were 
obtained from the Oral Cancer Research and Coordinating Centre (OCRCC), 
University of Malaya, Kuala Lumpur and used in this study, Additionally, 25 
serum samples were also collected from healthy individuals and used as control 
group. The cancer group consisted of patients with early stages of oral squamous 
cell carcinoma and without any history with other type of malignancy. The normal 
healthy individuals referred to individuals that were determined not to have any 
history with cancer. Samples obtained were with consent and approval granted by 
both universities; the Medical Ethics Committee, Dental Faculty, University of 
Malaya (UM) (Ref: DF OP0907/0050(P)) and Universiti Sains Malaysia (USM) 
(Ref: USMKK/PPP/JEPeM [213.3.09]). The serum samples were stored in 
aliquots of 10 µl and kept at -80°C until use.  
 
 
 
 
 
 
 
